Clinical trial
A Double-Blind, Placebo Controlled, Randomized, Cross-Over Polysomnographic Study of MK0928 15 mg in Adult Patients With Primary Insomnia
NCT00420810 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo Controlled, Randomized, Cross-Over Polysomnographic Study of MK0928 15 mg in Adult Patients With Primary Insomnia
- Lead sponsor
- H. Lundbeck A/S
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 2006
- Completion date
- Not reported
- Enrollment
- 138
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary insomnia